This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Statement of Retraction: miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMicroRNA in disease regulation
The Publisher of the journal Bioengineered, have retracted the following article:
Hongyan Zhanga, Feng Liangb, Fei Wanga, Qianru Xu, Yuxuan Qiu, Xin Lu, Lin Jiang, and Kaiyu Jian. miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2. 2021 Nov. doi: 10.1080/21655979.2021.2005742.
Since publication, significant concerns have been raised about the compliance with ethical policies for human research and the integrity of the data reported in the article.
When approached for an explanation, the authors provided some original data but were not able to provide all the necessary supporting information. As verifying the validity of published work is core to the scholarly record’s integrity, we are retracting the article. All authors listed in this publication have been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted.’